Skip to main content
Fig. 5 | Alzheimer's Research & Therapy

Fig. 5

From: Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

Fig. 5

Kaplan-Meier curves for conversion to Alzheimer’s disease (AD) in patients with significant memory complaint/mild cognitive impairment (MCI) according to baseline positron emission tomography (PET) profile (composite standardised uptake value ratio [SUVr]) and baseline cerebrospinal fluid (CSF) Amyloid-β1–42 (Aβ) and total tau profiles. ns Not significant. Cox model accounts for age, sex, apolipoprotein E status, baseline cognitive scores, PET profile, CSF Aβ and tau profiles

Back to article page